Literature DB >> 12505289

Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer.

Carol Sweeney1, Brian F Coles, Susan Nowell, Nicholas P Lang, Fred F Kadlubar.   

Abstract

Red meats cooked at high temperatures generate mutagenic heterocyclic amines, which undergo metabolic activation by hepatic cytochrome P450 1A2 and N-acetyltransferase-2. A primary detoxification pathway involves glutathione S-transferase A1 (GSTA1), which catalyzes the reduction of the carcinogenic N-acetoxy derivative back to the parent amine. Recently, we described a polymorphism in the GSTA1 proximal promoter; the variant (GSTA1*B) allele significantly lowers enzyme expression. In a case-control study, GSTA1*B/*B genotype was associated with an increased risk of colorectal cancer, particularly among consumers of well-done meat. Dietary nitrosamines, which are bioactivated by CYP2A6, represent another potential etiologic factor for colorectal cancer. CYP2A6 converts the caffeine metabolite 1,7-dimethylxanthine (17X) to 1,7-dimethyluric acid (17U); we investigated CYP2A6 activity using the 17U/17X urinary metabolite ratio from case-control subjects who completed a caffeine phenotype assay. The distribution of CYP2A6 activity was significantly different between CRCa cases and controls, with subjects in the medium and high activity groups having an increased risk (P for trend=0.001). GSTA1 genotype and CYP2A6 phenotype should be evaluated as markers of susceptibility to dietary carcinogens in future studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505289     DOI: 10.1016/s0300-483x(02)00259-7

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  7 in total

1.  Meta analysis of risk factors for colorectal cancer.

Authors:  Kun Chen; Jiong-Liang Qiu; Yang Zhang; Yu-Wan Zhao
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 2.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

3.  Relationship between metabolic enzyme polymorphism and colorectal cancer.

Authors:  Kun Chen; Qin-Ting Jiang; Han-Qing He
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

4.  Phenotypic CYP2A6 variation and the risk of pancreatic cancer.

Authors:  Susan Kadlubar; Jeffrey P Anderson; Carol Sweeney; Myron D Gross; Nicholas P Lang; Fred F Kadlubar; Kristin E Anderson
Journal:  JOP       Date:  2009-05-18

5.  Sex Differences in the Expression of Drug-Metabolizing and Transporter Genes in Human Liver.

Authors:  Lun Yang; Yan Li; Huixiao Hong; Ching-Wei Chang; Li-Wu Guo; Beverly Lyn-Cook; Leming Shi; Baitang Ning
Journal:  J Drug Metab Toxicol       Date:  2012-07-10

6.  Glutathione S-transferase alpha 4 induction by activator protein 1 in colorectal cancer.

Authors:  Y Yang; M M Huycke; T S Herman; X Wang
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 8.756

7.  Glutathione Transferase (GST)-Activated Prodrugs.

Authors:  Paolo Ruzza; Andrea Calderan
Journal:  Pharmaceutics       Date:  2013-04-02       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.